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The innovation systems approach to societal development includes a critique of 
the common focus on high technologies in the development process. Even in affluent 
economies, directing resources exclusively to high technologies neglects the broader 
innovative processes undertaken by doing, using, and interacting. In developing 
economies, with fewer resources, too strong a focus on high technologies is unlikely to 
produce as much benefit as a more inclusive concept of innovation. 
Emerging technologies are defined as those that are new, science-based, and of 
potentially broad impact (Cozzens et al., forthcoming). They are a particular subset of 
high technologies, located at what some call the technological frontier. Affluent countries 
compete for leadership in emerging technologies like bio- and nano-technologies, and 
some less affluent countries have in the past found significant opportunities in the wide 
open spaces of the technology emergence process.  
This paper looks at five examples of emerging technologies from the viewpoint of 
several developing countries, with particular attention to their distributional 
consequences. None of the examples represents the kind of dramatic opportunities that 
get so much attention in the innovation studies literature – there are no Koreas, Taiwans, 
or Singapores here. Precisely because of this, these cases may be more representative of 
the dilemmas emerging technologies present for countries that are trying to achieve 
inclusive growth.  
The paper presents some of the results from a cross-national, cross-technology 
study of the distributional effects of emerging technologies. The five technologies studied 
were: genetically modified (GM) maize, mobile phones, open source software, plant 
tissue culture, and recombinant insulin. The eight countries included were: Argentina, 
Canada, Costa Rica, Germany, Jamaica, Malta, Mozambique, and the United States. Half 
are high-income and half are low or middle income countries. This paper focuses on the 
results of the study in the four low and middle income countries. 
Emerging technologies are a strategic research site for examining the interaction 
of inequalities between countries and inequalities within countries.2  Conceptually, we 
                                                 
1 This paper draws in particular on case studies done as part of Project Resultar on Argentina, Costa Rica, 
Jamaica, and Mozambique, by Isabel Bortagaray, Lidia Brito, Roland Brouwer, Mario Falcao, Sonia 
Gatchair, and Dhanara Thakur. The Mozambican case studies were done as Work Package Four of ResIST, 
a project funded by the European Commission (see http://www.resist-research.net/home.aspx). Mark Knell 
is co-leader of that work package with Susan Cozzens. The case studies in the Americas were funded as 
Project Resultar by the U.S. National Science Foundation under Grant SES 072-6919. All opinions, 
findings, conclusions and recommendations are those of the author and do not necessarily reflect the view 
of the sponsors 
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defined emerging technologies in this project as new and research-based, with potential 
broad impact. Operationally in the project, we have studied the actual distributional 
consequences of selected biotechnologies and information and communication 
technologies (ICTs). The research aims to  
1. describe the dynamics that link emerging technologies to patterns of inequality; 
2. identify the roles of public interventions in those dynamics; and 
3. develop a framework that policy actors can use prospectively to analyze the 
distributional valence of a specific new technology in a particular national 
context. 
Our central research question is how policy interventions affect distributional outcomes 
for the same technology under different national conditions.  
Studying Emerging Technologies 
Why study emerging technologies in this project? First, precisely because they are 
new, emerging technologies are the site of change and growth in both global and local 
economies. The techno-economic networks that support them are still young and 
malleable, but are projected to be more significant as time goes on. They therefore 
represent a good place for public interventions towards equality, if such interventions 
were needed. Second, because emerging technologies are research-based, they are more 
likely to be sold at high prices (as firms try to recoup research and development costs) 
and to demand high levels of skills in the production process. Both these characteristics 
give emerging technologies a higher potential than older technologies for increasing 
inequalities in access and employment. 
Third, emerging technologies stand at the intersection of global and national 
distributive processes. The dominant pattern in emerging technologies has been that new 
technologies have been developed in North America, Europe, or North Asia (the “Triad” 
regions), then diffused to other parts of the world, either when a multi-national firm 
decides to place a production facility there or when the technology becomes available for 
purchase. The benefits and costs that people experience in the creating, producing, and 
using countries experience as a result of this process vary greatly among countries and 
technologies, but the global pattern of inequality may seem well established. Technology-
creating countries will always appear to be those starting the revolutions, and technology-
using countries will always appear to be trying to catch up, when we consider only this 
pattern.  
To create a different pattern, however, many non-Triad countries invest in their 
local capabilities in emerging technologies, not only to provide better absorptive 
                                                                                                                                                 
2 Any attempt to develop a crisply defined research agenda on inequality is challenged by the many 
dimensions of the phenomenon. At a very fundamental level, Sen (1992) points out that inequality is a 
multi-dimensional space, with different observers valuing different “focal inequalities,” from abstract 
property rights through basic human needs. Empirically, there are income inequalities between and within 
countries; vertical and horizontal inequalities within countries; inequalities in other areas like computer 
access (the “Digital Divide”), health outcomes (“health disparities”), and environmental conditions 
(“environmental injustice”). Inequality and inequity are different concepts -- one descriptive, one normative 
– although they are seldom carefully sorted out (see Cozzens 2007 for a discussion in S&T policy). 
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capacity, but also as the basis for using the emerging technology to meet local needs and 
create local competitive advantage. Indeed, the Millennium Project task force on 
innovation (Juma and Lee 2005) recommended that every developing country invest in 
three “platform technology” areas, namely, biotechnology, ICTs, and nanotechnology. 
These investments might create a re-distributional pattern with significant implications 
for the relationships between technologies and inequalities.  
Our study has provided an opportunity to examine both of these patterns in action. 
We assumed that reality is more complex than either the “dominating North” or 
“optimistic South” views, and we set out to describe the actual distributional dynamics 
generated by emerging technologies in various national contexts. 
Initial Concepts 
The basic logic of the data gathering and analysis has been that technological 
projects affect inequalities in valued items through pathways that are technology-specific, 
mediated by national conditions, and shaped by public interventions. Before turning back 
to the specific technological projects the study is examining, let us pause over each of 
these other concepts. 
The term technology above is shorthand for the concept of technological projects, 
that is, organized efforts of a group or institution. While private industry is the main 
source of technological projects, public institutions or civil society groups may also put 
them into motion. The study is based on the assumption that technological projects are 
always inherently distributional, and that the distributional aspects of individual projects 
and portfolios of projects are open to choice.  
Inequality is the unequal distribution of something people value. This project has not 
only considered inequality in incomes, the focus of the economic literature on the topic, 
but also inequalities in the distribution of the benefits and costs of technological projects. 
We explicitly include both vertical inequalities (the rich-poor dimension) and horizontal 
inequalities (differences by gender, ethnicity, or other culturally defined factors).  
In this project, we have focused on inequalities in three valued items, each generated 
through a different relationship to the emerging technology: business opportunities, 
employment, and benefits/costs. Since under our definition, emerging technologies are 
research-based, innovation plays a strong role in bringing them into being, when the other 
necessary forms of capital and organizational skill are present. This is the process of 
technology creation. New intellectual capital for one actor can destroy the value of the 
intellectual property of another as, for example, when synthetic fibers undermined natural 
fiber-based industries and devalued knowledge and skills many developing countries 
possessed. Conflicts over intellectual property are a common feature of the process of 
incorporating an emerging technology into a national context. We have therefore 
included examination of the distributional aspects of those issues in our study. The 
ownership of intellectual property has been treated in context as part of capital 
accumulation and business ownership. 
Relatively few jobs are associated with the creation of technology, but many are 
generated when the technology goes into production, marketing, and sales. Competition 
among countries for manufacturing production jobs is fierce, and technology-creating 
countries do not always win. Jobs can be generated directly, through production or sales 
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of the technology, indirectly through raising the productivity of another business, or 
indirectly as the wages of workers in the new or expanding industry are spent in the local 
economy (the multiplier effect). Production jobs in ICTs or pharmaceuticals can 
significantly affect small economies, as can successful commercial agriculture. However, 
the higher labor productivity of new production processes may mean that fewer jobs are 
generated through these processes than through other industries, and they may be 
accessible to a narrower segment of the population. Employment is thus a key variable 
we have tracked in our analysis.  
Technologies are ultimately designed to deliver benefits in health, food, environment, 
etc. through use. These benefits are technology-specific, as are the costs that might be 
generated in a specific national context. For example, the benefit from insulin would be 
better control of blood sugar and improved quality of life for diabetics, but if the insulin 
is only available to affluent consumers, these benefits could increase health disparities. 
To receive benefits, people must have access to the technology, through private purchase 
or public procurement, so in each case study we have characterized access to the 
technology in question. .  
The distributional effects of technological projects are mediated through a variety of 
national conditions, which are seldom discussed in the literature on technological 
impacts. As a starting point in analyzing the effects of these conditions, we described our 
case study countries in terms of national income level, poverty, general human capital in 
the form of educational attainment and specialized training of the nation’s citizens, and 
technological capability. The last is a complex concept, only imperfectly captured in the 
many current indicators and indexes related to it, and we looked for its presence beyond 
the indicators in our cases. These are the kinds of general factors that we expected to be 
associated with common patterns across technologies within countries. 
Finally, because it was oriented to a policy audience, our study characterized the 
policy instruments available to S&T decision makers to influence distributional 
consequences. We refer to these generically as public interventions, because they 
constitute a mix of policies, programs, and other kinds of actions. These interventions 
may either act to shape the technological projects themselves, for example through inputs 
from public research programs or incentives to firms, or by affecting national conditions, 
for example, through investments in education to build human capital. Likewise, the 
absence of public intervention can influence technological projects profoundly, for 
example, the inability to establish a regulatory environment that creates trust.  
Our early consultations with policy audiences about the project3 produced an initial 
list of candidate areas for public intervention, including regulatory policies (e.g., 
biosafety regulations that affect whether small or large farmers are more likely to benefit 
from planting a new crop); ownership provisions, for example, loose or tight intellectual 
property protection; shaping employment options through labor regulations; targeting 
specific technologies for faster development through public research; public procurement 
policies that provide markets for particular technologies, for example, health service 
                                                 
3 Project ResIST began with world regional consultations with policymakers in Africa, Latin America, and 
Europe.  
DRAFT April 5, 2009 
 5
purchases of recombinant insulin; and policies that develop human capital through 
specific training or general educational opportunities. 
Figure One. Basic Model 
 
Choice of Technologies 
 We chose to study these issues through case studies because of the complexity of 
the relationships we are studying and the importance of context. As a team, we are very 
familiar with the available quantitative indicators, and therefore skeptical that they reflect 
the complexity of the dynamics we want to study. Our qualitative approach allowed us to 
put quantitative information in context, and at the same time to describe and compare 
factors that could not be included in a statistical analysis.  
We chose technologies for case studies in light of our exploration of the literature 
and the conceptual framework of the study. One criterion was newness; we ruled out 
much older information and communication technologies like telephones and computers. 
Another criterion was relevance across the range of countries in the study. We would 
gain much less insight studying technologies that were only relevant in affluent countries. 
We tried to respond to opportunities arising from our team’s experience and connections, 
and we attempted to balance the set in terms of the technological projects of large 
corporations versus smaller challengers. 
In the ICT area, we focus first on mobile telephones. They are nearly ubiquitous: 
we have been able to study the mobile phone business in every country included in the 
study. The specific inventions that go into each mobile handset have origins in a number 
of different countries, and production is done on a distributed global basis. Furthermore, 
this technology is still evolving, with the emergence of third generation (3G) standards 
that are outside mainstream use in most countries (except Japan and South Korea). There 
are a number of creative uses of the technology, including by female entrepreneurs 
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service is a public utility, we expected to see a variety of public interventions in our 
cases. Indeed our preliminary review of national ICT policies in Africa, Asia, and the 
OECD countries, based on 62 policy documents available in English, showed wide 
variation in approaches, with nearly a third mentioning social inclusion or redistribution 
as one goal of the policy.4  
To provide a counter-balance to the corporation-centered story of the mobile 
phone industry, we have also explored the open source software movement. Even in the 
poorest country of our group, Mozambique, small businesses were growing up based on 
customization of open source software. The open source movement represents an 
alternative, democratized form of innovation (von Hippel 2005), and has raised policy 
issues like the current debate on whether the European Union should use Linux 
exclusively as its operating system (Thurston 2007).  
In biotechnology, we divided our choice of cases into agricultural and health 
areas, which are quite distinct in industrial connections, production processes, and users. 
A good list exists of the genetically-modified crops in production worldwide and the 
countries that plant them (James 2005). We were surprised to find that we could study a 
common genetically-modified crop planted in most of the countries of the study.  Again, 
we chose a technology that has received less attention in the past. The literature on social 
impacts of GM crops has focused on soy and Bt cotton. GM maize, our case study 
technology, is in production in several countries in Europe as well as widely in the 
Americas and in South Africa. 
There were, however, at the time we planned our study, only 21 countries in the 
world that were planting genetically-modified crops, including only one in Africa (James 
2005). To limit our study of agricultural biotechnology to these crops would have kept us 
from exploring why biotechnological capability is so high on the agendas of S&T 
policymakers in a much broader set of countries. We therefore decided also to include 
case studies of the application of a much older biotechnology technique, plant tissue 
culture (PTC). Again, Mozambique provided a vivid example that helped us choose this 
focus: While the technique is about 30 years old in the North, tissue culture of plants has 
only been possible in Mozambique in the past few years, through a new facility 
constructed with funds from the U.S. Agency for International Development. Following 
through on the lesson learned from this story, we included analysis of several different 
locally-important crops that were reproduced through tissue culture in the various 
countries in the study. The obvious candidate in Costa Rica was bananas, where almost 
all banana plants are grown in a laboratory, with 50% of the production by multinationals 
and the other 50% by 35 independent farmers. The focal crop across some other countries 
was potatoes, one of the fastest-growing food crops in the world.  
Finally, we wanted a technology example from health biotechnology. Of the 256 
biotechnology-based drugs approved by the U.S. Food and Drug Administration at the 
time our study started,5 only a few fell in areas where the World Health Organization has 
                                                 
4 This review was done by Dhanaraj Thakur. 
5 Approved Biotechnology Drugs – Biotechnology Industry Organization 
http://www.bio.org/speeches/pubs/er/approveddrugs.asp   Accessed Jan.02, 2007 
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identified “essential medicines,” important for developing countries.6 A considerable and 
sometimes charged literature already exists on one such category, the drugs for 
HIV/AIDS (see for example Dodier 2005, Homedes 2006, Galvao 2005, Baghadi 2005). 
We chose a quieter case for our analysis. Recombinant insulin was the very first 
biotechnology-based drug approved by the U.S. Food and Drug Administration (Walsh 
2005), and thus had the longest history of distributional consequences to trace. It is an 
important drug, becoming more important by the year as the global epidemic of diabetes 
expands (World Health Organization 2003). As with mobile phones, we were able to 
study the use of recombinant insulin in every country in the study. While it was 
developed first in the United States and one U.S. firm still produces it, the largest 
producer is now Novo Nordisk, a Danish firm, which markets recombinant insulin in 179 
countries. Social responsibility is a hallmark of Novo Nordisk, which is well known for 
working with non-governmental organizations, and operates with a “triple bottom line,” 
that is, financial, environmental, and social sustainability. The case thus gave us a chance 
to contrast business styles and philosophies.  
Choice of Countries 
 Our partner project ResIST confined its efforts to three world regions, Europe, 
Africa, and Latin America/Caribbean, making the judgment that available resources did 
not permit the inclusion of Asia in its empirical studies, as important as developments 
there are. Resultar followed the lead of our partner project in this. The ResIST 
participants studied selected target technologies in their own countries: Germany, Malta, 
and Mozambique, and followed GM maize into the Czech Republic. The Resultar team 
has complemented their efforts with a range of case studies in the Americas. In the end, 
the set included four “developed” countries and four “developing” ones, with a range of 
national income levels within each group.  
 
Table One: Countries 






Population7 38.7m 32.3m 4.3m 2.7m 296.5m 82.5m 404,000 19.8m 





.381 .589 .358  .733 .583 na .066 
 
                                                 
6 WHO Model List of Essential Medicines http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf  The WHO 
Essential Medicines list comprises the most efficacious, safe, cost-effective medicines for priority 
conditions.  
7 World Bank, World Development Indicators, data for 2005  
8 Gross National Income per capita, World Bank, World Development Indicators, data for 2005 
9 United Nations, Human Development Report 2001. 
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Methods 
 Our method is comparative case study. Each case is a technology-country pair, as 
indicated in the table below. We have gathered information for each case using a 
common protocol, drawing information from published sources and interviews. We are in 
the process of coding the reports on each case in NVivo, a qualitative analysis software 
tool, using a common set of categories: national conditions, technological project, public 
policy sphere (including public interventions), distributional consequences in business 
opportunities, employment, benefits and costs. Using this analysis, various team members 
have produced integrative chapters for each technology. The team leaders are in the 
process of synthesizing findings across the technologies. Team members are also 
identifying policy implications within the national contexts they have studied. 
Table Two: Case Study Matrix 
  AR CA CR Ger Jam Mal MZ US 
Mobile phones (8) XX XX XX XX XX XX XX XX 
Open source (6) XX XX XX XX   XX XX XX 
rDNA 
Insulin (7) 
XX XX XX XX 
EU 
XX XX XX XX 
GM maize 
(5) 
XX XX XX     XX 
CZ 
  XX 
Tissue cultured crop 
(4) 
XX XX XX   XX   XX XX 
 
Selected Results 
 One of the main lessons learned from the cases concerns diversity. On the one 
hand, the specific distributional consequences of the technologies are quite different and 
are clearly strongly influenced by all the factors displayed in the model: how the 
technological project was shaped by its champions; national conditions, in particular 
skills and poverty; and public interventions. On the other hand, the public interventions in 
each technology were relatively standard. And the overall distributional patterns followed 
some general patterns that we were able to see much more clearly from the comparison 
than we could have from individual cases.  
In an earlier paper,10 we discussed at length the lessons learned with regard to 
various parts of the model, so we only summarize here the main points of that analysis.  
  The technological project was quite an important concept in the study. Each 
technology was shaped differently both by its champions and by the policy 
environment into which it was introduced. These differences profoundly affected 
both the business opportunities connected to the technologies and consumer 
access. For example, the introduction of competition in mobile phone markets 
stimulated the introduction of pre-paid plans, which have had a huge impact on 
accessibility for low income consumers.  
                                                 
10 Cozzens et al., PRIME Latin America conference, Mexico City 2008.  
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  National conditions play a different role than we pictured when we started the 
project. Distributional consequences are not mediated by averages, like those 
given above for the case study countries, but rather by specific conditions for 
particular individuals, firms, or company. Some of the relevant conditions, 
however, are created by national governments, for example, an electricity 
infrastructure to underpin rural mobile networks.  (If those conditions are specific 
to the technology, then we include them under “public interventions” rather than 
“national conditions.”) 
  Public interventions, a somewhat broader concept than pubic policies and 
programs but closely related, are key variables in our analysis. As the focus 
technologies were being commercialized or applied, we found five main 
categories of interventions in the cases: public procurement; public utility 
oversight; anti-trust actions; health and safety regulations; and environmental 
protection. The first three are mildly to strongly re-distributive, while the latter 
two affect access negatively because while reducing overall risk they also raise 
costs.  
  With regard to the distribution of business opportunities, two factors were clearly 
significant. One was intellectual property protection. In some of our cases, 
multinational corporations held tight control of intellectual property around a new 
technology, limiting the opportunity for other firms to enter the market. A second 
constraint on business opportunity, however, is skill. If an environment does not 
have enough people at a high enough skill level to support or extend the 
technology, the ownership question is moot.  
  Direct employment effects of the emerging technologies in our study were small, 
with the exception of the mobile phone service industry. In mobile phones, new 
jobs were created directly with the new form of service, but as land line 
subscriptions begin to drop, jobs will be lost in that part of the telephone business. 
For the other technologies, high-technology manufacturing jobs tended to stay in 
affluent countries (e.g., in recombinant insulin), and there was a modest shift from 
lower-skilled, more dangerous jobs to somewhat higher-skilled, less dangerous 
ones. Our study did not include any of the countries that experienced rapid growth 
in employment through electronics manufacturing – indicating that those 
experiences may be the exception rather than the rule. 
  Considering the distribution of benefits and costs from the five technologies, we 
found a number of effects of public interventions (policies). Whether the product 
reached a particular consumer was usually due to a combination of action by the 
producing firm and the receiving government, along with specific conditions 
within a consuming firm or family. It was definitely not the case that the 
technology inevitably dropped in price until it reached a mass market; public 
interventions played a big role in shaping the market. What we are calling the 
“distributional boundary” for each technology is drawn by a combination of 
ownership structure, specialized skills, general educational levels, and 
infrastructure – and price, which is itself often influenced by competitive 
conditions set by the state.  
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The Technological Transition 
We are beginning to tie these various observations together with a new concept, a 
structural feature of the global economy that we call the technological transition.11 One 
set of diffusion and adoption dynamics is characteristic above the transition point and 
another set below. Predictable shifts in dynamics therefore occur for any given 
technology at the point of transition. We suspect that the transition point is probably 
closely associated with the global absolute poverty line, but that point is still under 
investigation. Regardless of where the actual transition appears, it comes along with 
differences in income distributions such that below the transition point will appear a 
disproportionate number of women and members of disadvantaged religious and ethnic 
groups.  
Above the transition point, champions can choose among luxury or mass markets 
for the products they create from the technological opportunity. Basic infrastructure can 
be taken for granted and champions must compete for the portion of a market created by 
the variety they offer. Technological choices involve relatively small shifts in costs in 
relation to income, and consumers have the resources and leisure to shop around. 
Below the technological transition point, the product may be irrelevant (open 
source software for people without electricity let alone computers) or downright 
dangerous (insulin in an urban slum). If the product reaches poor consumers at all, it is 
likely to be either in second-hand form (like the hand-me-down mobile phones common 
in Maputo) or broken down into small lots that cost more per unit (again, the higher rates 
per minute for pre-paid versus contract mobile phone access illustrate). They thus pay a 
larger share of their income to have access to the benefit, and the whole issue of benefits 
becomes more acute because the opportunity costs are relatively higher. The important 
questions then do not have to do with access per se, but rather with whether access might 
actually be counter-productive.  
Developing Country Experiences 
 The preceding summary of results tracks the technologies across all eight 
countries in the study. How do these dynamics look from the viewpoint of the four 
middle and low income countries we studied? A few summary observations will have to 
stand in for the fuller analysis that will be available in the country chapters of the book 
we are preparing. Again, I draw here on the work my colleagues in Resultar and ResIST 
have reported.12 
 First, it is not true that emerging technologies always emerge in the North. Insulin 
(at least the traditional kind) was purified in Argentina first, in the 1920s. But the U.S. 
drug company Lilly moved in quickly and bought out the Argentine interest in the 
product, then produced it there (close to a good supply of the pig pancreas it was purified 
from) for many years, until recombinant insulin disrupted this symbiotic business 
                                                 
11 This is an analogy to a concept in public health of the epidemiological transition: that one set of diseases 
characterizes countries with incomes up to a certain level, after which certain infrastructural conditions 
have been met and a different set of diseases emerges against the background of generally good public 
health. The first set is the “diseases of poverty” and the second set “the diseases of affluence.” 
12 We hope the working papers will be available in 4-6 weeks through links at www.tpac.gatech.edu. 
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relationship by removing the need for the raw material.13 The story is an even more 
familiar one today – large multinationals buy out the intellectual property of small firms 
in the South. It illustrates that the key to taking advantage of emerging technologies is not 
invention or discovery, but ownership and business opportunity.  
 Business opportunities. Across the four developing countries, there is significant 
variation in the extent to which local businesses grow up around the technologies. 
Argentina makes the strongest showing in this regard, with insulin production still 
happening there, partly based on the production facility left behind by Lilly but certainly 
supported by local biomedical expertise. Local seed companies co-exist with huge 
Monsanto operations around genetically-modified crops, including our case of maize. 
Outside the life sciences, however, the pattern breaks: mobile phones are entirely 
imported in Argentina and we could find no business activity in open source software.  
In Costa Rica, a country with a similar level of wealth, local business was clearly 
supported by a significant plant tissue culture operation, in a research facility supported 
by the banana industry.14 But this was the only private business activity linked to our five 
technologies there. The puzzle in Costa Rica is why the significant local software 
industry does not generate any discernible open source business activity. In general 
across the countries, a local software industry is a necessary condition for open source 
businesses to spring up; but apparently it is not a sufficient one.  
Another potential business opportunity that did not appear is plant tissue culture 
in Jamaica. There is an appropriate facility, used in a previous project with the European 
Union.15 PTC does not need to be limited to bananas – planting materials for other local 
vegetatively-propagated crops could be produced and sold. A few hundred miles away, in 
Florida, a thriving plant tissue culture industry thrives. Why not in Jamaica?  
In Mozambique, the technologies provide interesting support to livelihoods at the 
micro level.16 While mobile phone companies do not employ very many people, they do 
provide opportunities for hundreds of street vendors in Maputo to sell recharge cards on 
every street corner. And tissue cultured planting materials, prepared in a government 
laboratory and distributed by international aid organizations, provide some help for 
subsistence farmers, many of them women, with perhaps some movement of the product 
involved into local markets.  
In short, the variable experiences of our low and middle income countries show 
the business opportunities generated by emerging technologies depend crucially on the 
technical capabilities that already exist in a local environment, but also on some other set 
of complementary conditions that we were not able to identify. Low technical capabilities 
lead to small business opportunities. Higher technical capabilities bring the possibility of 
larger business opportunities, which innovation policies might be able to target.  
Employment.  As noted earlier, no major shifts in employment were visible in any 
of our case studies. The shift that seemed most likely was the substitution of recombinant 
for porcine-based insulin that affected the production facility in Argentina; but local 
                                                 
13 Bortagaray, Argentina-insulin case.  
14 Bortagaray, Costa Rica banana case. 
15 Gatchair, Jamaica plant tissue culture case. 
16 Brito, Brouwer, and Falcao, Mozambique cases. 
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action prevented the plant from closing and a local market maintains it.17 The contrast 
with cases in which production of high-technology products has moved to developing 
countries is striking, and illustrates how limited those other experiences are, and how 
hard it is to generalize from them to other developing countries. 
Benefits and costs.  All the technologies we studied were widely accessible in 
Argentina, Costa Rica, and Jamaica, with some rather specific holes in coverage. The 
wide availability of recombinant insulin was largely as a result of health insurance and 
public health services, so where someone did not have access, it was because they were 
not covered – a situation that characterized a surprising 25% of Argentines and probably 
the full 40% of Jamaicans who work in the informal economy. Another hole in 
accessibility, this time of mobile phone hand sets, was caused by the government 
telecommunications monopoly in Costa Rica, which managed to put a lot of obstacles in 
the way of acquiring the set – after which, service was cheap. With banana tissue culture 
material, small farmers were likely not to be able to afford the materials, since they were 
not produced locally. Larger farmers could import what they needed. Access to a basic 
level of the technology of course did not imply access to the best version that was 
available (the different versions of insulin illustrate), but mostly people living in middle 
income countries are on the positive side of the distributional boundary. 
The situation was different in Mozambique.18 Since there are only 20,000 
computers in this country of 20 million, not many would have been able to benefit from 
open source software. Mobile phones are heavily concentrated among male users in 
Maputo, according to a telephone survey done by our Mozambican team. And for the 
estimated 80,000 diabetics in the country, only enough insulin for perhaps 50-100 is 
imported. (Affluent Mozambicans in the south of the country can drive to South Africa 
and buy insulin over the counter in drug stores.) Doctors in Mozambique are reluctant to 
prescribe insulin to people in poor households who will not be able to maintain the 
necessary regimen. So ironically, while insulin is free through the public health service 
there, rich people are much more likely to benefit from that policy than poor ones. 
Likewise, ironically, pre-paid phone plans make mobiles accessible to poor consumers, 
but they pay more per minute used.  
None of these limitations is inevitable, as the story of the tissue-cultured orange 
flesh sweet potato plantings in Mozambique illustrates. When government and NGOs 
decide to work together to diffuse a useful technology, they can be successful, especially 
with a community-based multi-pronged approach involving education and subsidies. Our 
Mozambican colleagues recommend policies that incorporate these elements for other 
technologies as well. 
Policy Options 
Clearly, there is no one-size-fits-all set of recommendations that can be made 
based on our findings, even among these four “developing” countries. For each country 
represented in our study, we have prepared an essay pointing to patterns across the 
technologies and policy options that make sense in that country’s context.  
                                                 
17 Bortagaray, Argentina insulin case. 
18 Brito and Brouwer, Mozambique country essay. 
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Our Mozambican colleagues have provided a particularly detailed analysis of 
policy options for using emerging technologies in resource-poor environments for 
inclusive development.19 They use concepts from another part of the ResIST project to 
place the technologies on three dimensions of inequality: structural, representational, and 
distributional.20 These generate ideas for multiple approaches to reducing inequalities in 
the distribution of benefits and costs while building capacity for society and economy.  
Let me end with a key feature of their discussion.21 Emerging technologies do not 
have to diffuse passively into developing countries. National governments can choose to 
work on absorbing ones that make a difference locally and hold the potential for 
increasing the innovative capacity of the country. Such selections need to be surrounded 
by training, supported with facilities, and stimulated through community participation. If 
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19 Idem. 
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21 Brito and Brouwer, Mozambique country essay.  
